Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 5, 2018

Primary Completion Date

September 16, 2021

Study Completion Date

September 16, 2021

Conditions
SpondyloarthritisCrohn DiseaseUlcerative Colitis
Interventions
OTHER

blood sample

14 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation

OTHER

stool samples

Study of the fecal microbiota

OTHER

food questionnaire

food questionnaire on the seven days before the collection

OTHER

colonoscopy

Only for patients with ulcerative colitis (in routine care)

OTHER

VOCs profile

Volatile Organic Compounds (VOCs) profile obtained by mass spectrometry

Trial Locations (1)

Unknown

CHU de Bordeaux - service d'Hépato-gastroentérologie, Pessac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT03359642 - Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy | Biotech Hunter | Biotech Hunter